ALIVE

ALIVE invests across the full venture spectrum — seed, early-stage, and growth — within a single integrated strategy. The firm deploys capital from initial startup formation through expansion rounds, which suggests a concentrated, high-conviction portfolio rather than a spray-and-pray seed model. This stage-agnostic approach is less common in the Israeli market, where venture firms typically segment by fund vintage.

ALIVE blends characteristics of both models. It operates as a venture capital firm deploying external capital, but its multi-stage, hands-on approach resembles a venture studio that remains closely involved with portfolio companies across their lifecycle. Without disclosed team bios or portfolio specifics, the exact operational model remains a matter of inference based on its stated co-investment and stage-spanning mandate.

Based on public record, ALIVE's primary geographic focus is Israel, where it is headquartered. There is no confirmation of additional offices or a formal mandate to invest outside the country. Israeli venture firms of ALIVE's profile often concentrate domestically given the density of deal flow in sectors like cybersecurity, enterprise software, and AI infrastructure.

Specific sourcing channels are not publicly disclosed. Given the firm's early-stage orientation and single-market focus, deal flow likely originates through founder networks within Israel's technology ecosystem, co-investor relationships, and direct inbound from startups. Israeli seed-stage sourcing is heavily relationship-driven, and firms without a large platform team typically rely on deep local network effects.

Yes. ALIVE's described strategy explicitly includes co-investment, indicating a willingness to participate in syndicates alongside other venture capital firms. This suggests the firm does not require a lead-investor position in every deal and can operate as a follow-on or co-lead in rounds structured by larger Israeli or international VCs.